Your session is about to expire
← Back to Search
Flavonoid
Quercetin Phytosome for Quercetin
N/A
Waitlist Available
Led By Stephen Phipps, ND, PhD
Research Sponsored by Thorne Research Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group
Summary
This Trial will test if quercetin can enhance metabolic health over a few months. Participants will take a special form of quercetin to see if it improves cholesterol, blood sugar, and other health markers. Quercetin has been studied for its potential effects on metabolic health, including improvements in insulin sensitivity, blood pressure, and lipid profiles.
Eligible Conditions
- Quercetin
- Metabolism of Lipids
- Aging
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Apolipoprotein B from before (day 0) to after (day 90) supplementation
Change in Biological Age score from before (day 0) to after (day 90) supplementation
Change in Lipoprotein Fractions from before (day 0) to after (day 90) supplementation
+1 moreSecondary study objectives
Lifestyle changes from before (day 0) to after (day 90) supplementation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Quercetin PhytosomeExperimental Treatment1 Intervention
All participants will receive Quercetin Phytosome
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Quercetin Phytosome
2020
Completed Phase 3
~160
Find a Location
Who is running the clinical trial?
Thorne Research Inc.Lead Sponsor
10 Previous Clinical Trials
449 Total Patients Enrolled
Thorne HealthTech, IncLead Sponsor
10 Previous Clinical Trials
449 Total Patients Enrolled
Indena S.p.AIndustry Sponsor
9 Previous Clinical Trials
562 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger